Skip to main content

Advertisement

Log in

Subcutaneous tunneling of the temporary testing electrode significantly improves the success rate of subchronic sacral nerve modulation (SNM)

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Sacral nerve modulation (SNM) is an effective way to treat non-neurogenic dysfunctions of pelvic organs. For over 20 years, this technique has been used for the treatment of overactive bladder, urinary retention, pelvic pain and even more recently, fecal incontinence and constipation. The objective of the study is to improve the fixation of the temporary testing electrode (TTE) in order to obtain more reliable results in the testing phase which should lead to have a comparable success rate as the two-stage implant for a chronic implant. Twenty-eight patients (ratio of sex women:men = 3:1; with overactive bladder, urinary retention, pelvic pain syndrome and fecal incontinence) were evaluated by the modified temporary test electrode (TTE) placement. With the subcutaneous tunneling technique (mean time of evaluation 8.3 days), it is possible to perform percutaneous nerve evaluation (PNE) more effectively with an objective, reliable and less expensive outcome prior to the implantation of the implantable sacral nerve stimulator in almost 80% of the evaluated patients. Because the costs of therapy are not covered by health insurance in all countries, there is a need for an effective and inexpensive way to test and select patients appropriately. The tunneled TTE maintains its place for consistent amplitude during the entire test duration. The modification of placing the TTE produces repayable results. This technique can be performed on an outpatient basis to evaluate sacral nerve modulation as an early treatment option for non-dysfunctions of pelvic organs before they are forwarded to a specialized center for a chronic SNM implantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Scheepens WA, Jongen MM, Nieman FH, de Bie RA, Weil EH, van Kerrebroeck PE (2002) Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction. Urology 60(4):598–602

    Article  PubMed  CAS  Google Scholar 

  2. Spinelli M, Giardiello G, Arduini A, van den Hombergh U (2003) New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results. Eur Urol 43(1):70–74

    Article  PubMed  Google Scholar 

  3. Spinelli M, Giardiello G, Gerber M, Arduini A, van den Hombergh U, Malaguti S (2003) New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol 170(5):1905–1907

    Article  PubMed  Google Scholar 

  4. Kessler TM, Madersbacher H, Kiss G (2005) Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?. Eur Urol 47(5):660–665

    Article  PubMed  Google Scholar 

  5. Scheepens WA, Weil EH, van Koeveringe GA, Rohrmann D, Hedlund HE, Schurch B, Ostardo E, Pastorello M, Ratto C, Nordling J, van Kerrebroeck PE (2001) Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation: a multicenter study. Eur Urol 40(4):434–438

    Article  PubMed  CAS  Google Scholar 

  6. Siegel SW (2005) Selecting patients for sacral nerve stimulation. Uro Clin N Am 32:19–26

    Article  Google Scholar 

  7. Pannek J, Grigoleit U, Hinkel A (2005) Bacterial contamination of test stimulation leads during percutaneous nerve stimulation. Urology 65(6):1096–1098

    Article  PubMed  Google Scholar 

  8. Elhilali MM, Khaled SM, Kashiwabara T, Elzayat E, Corcos J (2005) Sacral neuromodulation: long-term experience of one center. Urology 65(6):1114–1117

    Article  PubMed  Google Scholar 

  9. van Voskuilen AC, Oerlemans DJAJ, Weil EHJ, de Bie RA, van Kerrebroeck PEVA (2006) Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol 49:366–372

    Article  PubMed  Google Scholar 

  10. Hampl C, Gillitzer R, Pahernik S, Melchor SW, Thuroff JW (2005) [Drug Therapy of female urinay incontinence]. Urologe A 44(3):244–255

    Article  Google Scholar 

  11. Siegel SW, Catanzaro F, Dijkema HE, Elhilali MM, Fowler CJ, Gajewski JB, Hassouna MM, Janknegt RA, Jonas U, van Kerrebroeck PE, Lycklama a Nijeholt AA, Oleson KA, Schmidt RA (2000) Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology 56(6 Suppl 1):87–91

    Article  PubMed  CAS  Google Scholar 

  12. Frenkl TL, Rackley RR (2005) Injectable neuromodulatory agents: botulinum toxin therapy. Urol Clin North Am 32(1):89–99

    Article  PubMed  Google Scholar 

  13. Amundsen CL, Romero AA, Jamison MG, Webster GD (2005) Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology 66(4):746–750

    Article  PubMed  Google Scholar 

  14. Elkelini M, Hassouna MM (2005) Canadian experience in sacral neuromodulation. Urol Clin North Am 32(1):41–49

    Article  PubMed  Google Scholar 

  15. Daneshgari F, Moy ML (2005) Current indications for neuromodulation. Urol Clin North Am 32(1):37–40

    Article  PubMed  Google Scholar 

  16. Jarrett ME, Mowatt G, Glazener CM, Fraser C, Nicholls RJ, Grant AM, Kamm MA (2004) Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg 91(12):1559–1569

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karl-Dietrich Sievert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sievert, KD., Nagele, U., Pannek, J. et al. Subcutaneous tunneling of the temporary testing electrode significantly improves the success rate of subchronic sacral nerve modulation (SNM). World J Urol 25, 607–612 (2007). https://doi.org/10.1007/s00345-007-0204-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-007-0204-5

Keywords

Navigation